• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哈洛佩au连续性肢端皮炎对优化生物治疗的反应

Acrodermatitis continua of Hallopeau response to optimized biological therapy.

作者信息

Adas Alanoud, Dadban Ali, Arnault Jean-Philippe, Chaby Guillaume, Lok Catherine

机构信息

Department of Dermatology, Amiens University Hospital, Amiens.

出版信息

Dermatol Online J. 2019 Feb 15;25(2):13030/qt93s9w1p3.

PMID:30865417
Abstract

Acrodermatitis continua of Hallopeau, first described in 1890, is an uncommon variant of pustular psoriasis. It presents as a sterile pustular eruption of the tips of fingers and toes. The condition has a chronic, relapsing course and is often resistant to many anti-psoriatic therapies. In the following case, we present our experience of etanercept use in a 61-year-old man. Although initial therapy with high-dose etanercept achieved a rapid, sustained response and remission, the lesions relapsed a few months into a lower, maintenance dosage. This result prompted the use a second biotherapeutic agent ustekinumab, which resulted in complete remission, but required a higher dosage than recommended with reduced dosing intervals.

摘要

哈洛佩奥连续性肢端皮炎于1890年首次被描述,是脓疱型银屑病的一种罕见变体。它表现为手指和脚趾尖端的无菌性脓疱疹。该病病程慢性、易复发,且通常对多种抗银屑病疗法耐药。在以下病例中,我们介绍了一名61岁男性使用依那西普的经验。尽管初始使用高剂量依那西普治疗取得了快速、持续的反应和缓解,但在几个月后减至较低维持剂量时,皮损复发。这一结果促使使用第二种生物治疗药物乌司奴单抗,该药物导致了完全缓解,但所需剂量高于推荐剂量且给药间隔缩短。

相似文献

1
Acrodermatitis continua of Hallopeau response to optimized biological therapy.哈洛佩au连续性肢端皮炎对优化生物治疗的反应
Dermatol Online J. 2019 Feb 15;25(2):13030/qt93s9w1p3.
2
Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents.优特克单抗用于治疗对抗肿瘤坏死因子药物难治的Hallopeau连续性肢端皮炎。
Dermatol Ther. 2017 Mar;30(2). doi: 10.1111/dth.12460. Epub 2017 Jan 30.
3
The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.生物疗法在 Hallopeau 连续性肢端皮炎治疗中的应用:综述。
J Cutan Med Surg. 2019 Jul/Aug;23(4):428-435. doi: 10.1177/1203475419836435. Epub 2019 Apr 2.
4
Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.肿瘤坏死因子阻断治疗及阿那白滞素治疗失败后,用乌司奴单抗和阿维A成功治疗的Hallopeau连续性肢端皮炎。
Dermatology. 2015;230(2):97-100. doi: 10.1159/000367690. Epub 2014 Nov 27.
5
Acrodermatitis continua of Hallopeau successfully treated with secukinumab.司库奇尤单抗成功治疗Hallopeau连续性肢端皮炎。
J Dermatolog Treat. 2018;29(sup1):3-5. doi: 10.1080/09546634.2018.1527993.
6
Treatment of acrodermatitis continua of Hallopeau with ustekinumab as monotherapy after failure of anti-TNF agents.在抗TNF药物治疗失败后,使用优特克单抗单药治疗Hallopeau连续性肢端皮炎。
J Dtsch Dermatol Ges. 2018 May;16(5):611-613. doi: 10.1111/ddg.13506. Epub 2018 Apr 16.
7
Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.司库奇尤单抗成功治疗合并泛发性脓疱型银屑病的Hallopeau连续性肢端皮炎:一例报告
Front Immunol. 2024 Feb 23;15:1338285. doi: 10.3389/fimmu.2024.1338285. eCollection 2024.
8
Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting.中度至重度银屑病生物治疗中的剂量调整:临床实践环境中的描述性分析
Actas Dermosifiliogr. 2015 Sep;106(7):569-77. doi: 10.1016/j.ad.2015.02.003. Epub 2015 Apr 30.
9
Treatment of acrodermatitis continua of hallopeau with ixekizumab.以依奇珠单抗治疗 Hallopeau 连续性肢端皮炎。
J Dermatolog Treat. 2021 Feb;32(1):117-119. doi: 10.1080/09546634.2019.1628170. Epub 2019 Jul 5.
10
Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report.用比美吉珠单抗成功治疗的哈洛佩奥连续性肢端皮炎:一例报告
SAGE Open Med Case Rep. 2023 Mar 21;11:2050313X231160937. doi: 10.1177/2050313X231160937. eCollection 2023.

引用本文的文献

1
Acrodermatitis continua of Hallopeau: a review and update on biological and small molecule targeted immunomodulatory therapies.哈洛佩奥连续性肢端皮炎:生物和小分子靶向免疫调节疗法的综述与更新
Front Immunol. 2025 Aug 15;16:1525821. doi: 10.3389/fimmu.2025.1525821. eCollection 2025.
2
Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review.乌司奴单抗成功治疗Hallopeau连续性肢端皮炎:病例报告及文献综述
Clin Cosmet Investig Dermatol. 2023 Apr 6;16:951-957. doi: 10.2147/CCID.S404860. eCollection 2023.